ArticleResearch square2024

CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer.

Takumi Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.